113 related articles for article (PubMed ID: 15476325)
1. [Quantitative detection of telomere binding factor 2 gene expression in non-Hodgkin lymphoma with a real-time reverse transcription-polymerase chain reaction assay].
Qian WB; Meng HT; Jin J
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2004 Sep; 33(5):416-20. PubMed ID: 15476325
[TBL] [Abstract][Full Text] [Related]
2. Telomerase activity in B-cell non-Hodgkin lymphomas is regulated by hTERT transcription and correlated with telomere-binding protein expression but uncoupled from proliferation.
Klapper W; Krams M; Qian W; Janssen D; Parwaresch R
Br J Cancer; 2003 Aug; 89(4):713-9. PubMed ID: 12915884
[TBL] [Abstract][Full Text] [Related]
3. Determination of cyclin D1 and CD20 mRNA levels by real-time quantitative RT-PCR from archival tissue sections of mantle cell lymphoma and other non-Hodgkin's lymphomas.
Thomázy VA; Luthra R; Uthman MO; Davies PJ; Medeiros LJ
J Mol Diagn; 2002 Nov; 4(4):201-8. PubMed ID: 12411587
[TBL] [Abstract][Full Text] [Related]
4. Optimization of quantitative real-time RT-PCR parameters for the study of lymphoid malignancies.
Lossos IS; Czerwinski DK; Wechser MA; Levy R
Leukemia; 2003 Apr; 17(4):789-95. PubMed ID: 12682639
[TBL] [Abstract][Full Text] [Related]
5. Hidden gene amplifications in aggressive B-cell non-Hodgkin lymphomas detected by microarray-based comparative genomic hybridization.
Wessendorf S; Schwaenen C; Kohlhammer H; Kienle D; Wrobel G; Barth TF; Nessling M; Möller P; Döhner H; Lichter P; Bentz M
Oncogene; 2003 Mar; 22(9):1425-9. PubMed ID: 12618769
[TBL] [Abstract][Full Text] [Related]
6. [The role of stromal cell derived factor-1/CXCR4 biological axis in tumor metastasis of non-Hodgkin lymphoma].
Zhang C; Cui GH; Liu F; Wu QL; Chen Y
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):695-7. PubMed ID: 17553309
[TBL] [Abstract][Full Text] [Related]
7. Identification of cyclin D1 mRNA overexpression in B-cell neoplasias by real-time reverse transcription-PCR of microdissected paraffin sections.
Specht K; Kremer M; Müller U; Dirnhofer S; Rosemann M; Höfler H; Quintanilla-Martinez L; Fend F
Clin Cancer Res; 2002 Sep; 8(9):2902-11. PubMed ID: 12231535
[TBL] [Abstract][Full Text] [Related]
8. Coordinate regulation between expression levels of telomere-binding proteins and telomere length in breast carcinomas.
Butler KS; Hines WC; Heaphy CM; Griffith JK
Cancer Med; 2012 Oct; 1(2):165-75. PubMed ID: 23342266
[TBL] [Abstract][Full Text] [Related]
9. Sp1 upregulates expression of TRF2 and TRF2 inhibition reduces tumorigenesis in human colorectal carcinoma cells.
Dong W; Shen R; Wang Q; Gao Y; Qi X; Jiang H; Yao J; Lin X; Wu Y; Wang L
Cancer Biol Ther; 2009 Nov; 8(22):2166-74. PubMed ID: 19783902
[TBL] [Abstract][Full Text] [Related]
10. Discovery of novel epigenetic markers in non-Hodgkin's lymphoma.
Shi H; Guo J; Duff DJ; Rahmatpanah F; Chitima-Matsiga R; Al-Kuhlani M; Taylor KH; Sjahputera O; Andreski M; Wooldridge JE; Caldwell CW
Carcinogenesis; 2007 Jan; 28(1):60-70. PubMed ID: 16774933
[TBL] [Abstract][Full Text] [Related]
11. MRD Detection in B-Cell Non-Hodgkin Lymphomas Using Ig Gene Rearrangements and Chromosomal Translocations as Targets for Real-Time Quantitative PCR.
Pott C; Brüggemann M; Ritgen M; van der Velden VHJ; van Dongen JJM; Kneba M
Methods Mol Biol; 2019; 1956():199-228. PubMed ID: 30779036
[TBL] [Abstract][Full Text] [Related]
12. c-Myc oncogene and Cdc25A cell activating phosphatase expression in non-Hodgkin's lymphoma.
Aref S; Fouda M; El-Dosoky E; Menessy A; Mabed M; Saleeb M; Zalata K
Hematology; 2003 Jun; 8(3):183-90. PubMed ID: 12745652
[TBL] [Abstract][Full Text] [Related]
13. The Polymerase Chain Reaction in Diagnosis of Small B-Cell Non-Hodgkin Lymphomas.
Antoro EL; Dwianingsih EK; Indrawati ; Triningsih FE; Harijadi
Asian Pac J Cancer Prev; 2016; 17(2):491-5. PubMed ID: 26925633
[TBL] [Abstract][Full Text] [Related]
14. Optimization of quantitative real-time RT-PCR parameters for the study of lymphoid malignancies.
Levy R
Leukemia; 2003 Apr; 17(4):796-7. PubMed ID: 12682640
[No Abstract] [Full Text] [Related]
15. Statins enhance migratory capacity by upregulation of the telomere repeat-binding factor TRF2 in endothelial progenitor cells.
Spyridopoulos I; Haendeler J; Urbich C; Brummendorf TH; Oh H; Schneider MD; Zeiher AM; Dimmeler S
Circulation; 2004 Nov; 110(19):3136-42. PubMed ID: 15520325
[TBL] [Abstract][Full Text] [Related]
16. Non-Hodgkin lymphoma expressing high levels of the danger-signalling protein HMGB1.
Meyer A; Staratschek-Jox A; Springwald A; Wenk H; Wolf J; Wickenhauser C; Bullerdiek J
Leuk Lymphoma; 2008 Jun; 49(6):1184-9. PubMed ID: 18569640
[TBL] [Abstract][Full Text] [Related]
17. Constitutively overexpressed 21 kDa protein in Hodgkin lymphoma and aggressive non-Hodgkin lymphomas identified as cytochrome B5b (CYB5B).
Murphy D; Parker J; Zhou M; Fadlelmola FM; Steidl C; Karsan A; Gascoyne RD; Chen H; Banerjee D
Mol Cancer; 2010 Jan; 9():14. PubMed ID: 20100355
[TBL] [Abstract][Full Text] [Related]
18. Expression of telomere binding proteins in gastric cancer and correlation with clinicopathological parameters.
Gao J; Zhang J; Long Y; Lu X
Asia Pac J Clin Oncol; 2011 Dec; 7(4):339-45. PubMed ID: 22151982
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of the hPim-2 gene in human chronic lymphocytic leukemia and non-Hodgkin lymphoma.
Cohen AM; Grinblat B; Bessler H; Kristt D; Kremer A; Schwartz A; Halperin M; Shalom S; Merkel D; Don J
Leuk Lymphoma; 2004 May; 45(5):951-5. PubMed ID: 15291354
[TBL] [Abstract][Full Text] [Related]
20. [Expression of telomere binding factor 2 (TRF2) on leukemia cell lines and primary leukemia cells].
Chen XH; Tong Y; Xu WL; Jin J; Qian WB
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2008 Mar; 37(2):170-5. PubMed ID: 18422278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
